Correlation between unirradiated cell TP53 protein levels and radiosensitivity in MOLT-4 cells

Radiation Research

Volumn 151, Issue 6, 1999, Pages 686-693

  Nakano, Hisako ^a   Shinohara, Kunio ^b  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOHEXIMIDE; DNA; MESSENGER RNA; PROTEIN P53;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN CONTENT; RADIOSENSITIVITY; T CELL LEUKEMIA; TUMOR SUPPRESSOR GENE; X IRRADIATION;

ADULT; APOPTOSIS; CELL SURVIVAL; DNA FRAGMENTATION; HUMANS; MALE; PROTO-ONCOGENE PROTEINS C-BCL-2; RADIATION TOLERANCE; RNA, MESSENGER; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033022344     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.2307/3580207     Document Type: Article

References (57)

1. J. F. R. Kerr, A. H. Wyllie and A. R. Currie, Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26, 239-257 (1972).
2. A. H. Wyllie, Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284, 555-556 (1980).
3. E. White, Life, death, and the pursuit of apoptosis. Genes Dev. 10, 1-15 (1996).
4. P. R. Walker, C. Smith, T. Youdale, J. Leblanc, J. F. Whitfield and M. Sikorska, Topoisomerase II-reactive chemotherapeutic drugs induce apoptosis in thymocytes. Cancer Res. 51, 1078-1085 (1991).
5. D. G. Brown, X-M. Sun and G. M. Cohen, Dexamethasone-induced apoptosis involves cleavage of DNA to large fragments prior to internucleosomal fragmentation. J. Biol. Chem. 268, 3037-3039 (1993).
6. H. Nakano and K. Shinohara, X-ray-induced cell death: Apoptosis and necrosis. Radiat. Res. 140, 1-9 (1994).
7. A. Strasser, A. W. Harris, T. Jacks and S. Cory, DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell 79, 329-339 (1994).
8. T. Tamura, M. Ishihara, M. S. Lamphier, N. Tanaka, I. Oishi, S. Aizawa, T. Matsuyama, T. W. Mak, S. Taki and T. Taniguchi, An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes. Nature 376, 596-599 (1995).
9. A. Haimovitz-Friedman, C-C. Kan, D. Ehleiter, R. S. Persaud, M. McLoughlin, Z. Fuks and R. N. Kolesnick, Ionizing radiation acts on cellular membranes to generate ceramide and initiated apoptosis. J. Exp. Med. 180, 525-535 (1994).
10. P. Santana, L. A. Pena, A. Haimovitz-Friedman, S. Martin, D. Green, M. McLoughlin, C. Cordon-Cardo, E. H. Schuchman, Z. Fuks and R. Kolesnick, Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell 86, 189-199 (1996).
11. A. R. Clark, C. A. Purdie, D. J. Harrison, R. G. Morris, C. C. Bird, M. L. Hooper and A. H. Wyllie, Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362, 849-852 (1993).
12. S. W. Lowe, E. M. Schmitt, S. W. Smith, B. A. Osborne and T. Jacks, p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362, 847-849 (1993).
13. J. M. Lee and A. Bernstein, p53 mutations increase resistance to ionizing radiation. Proc. Natl. Acad. Sci. USA 90, 5742-5746 (1993).
14. S. Fan, W. S. el-Deiry, I. Bae, J. Freemann, D. Jondle, K. Bhatia, A. J. Fornace, Jr., I. Magrath, K. W. Kohn and P. M. O'Connor, p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. Cancer Res. 54, 5824-5830 (1994).
15. S. W. Lowe, S. Bodis, A. McClatchey, L. Remington, H. E. Ruley, D. E. Fisher, D. E. Housman and T. Jacks, p53 status and the efficacy of cancer therapy in vivo. Science 266, 807-810 (1994).
16. M. Fritsche, C. Haessler and G. Brandner, Induction of nuclear accumulation of the tumour-suppressor protein p53 by DNA-damaging agents. Oncogene 8, 307-318 (1993).
17. M. B. Kastan, O. Onyekwere, D. Sidransky, B. Vogelstein and R. W. Craig, Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51, 6304-6311 (1991).
18. M. B. Kastan, Q. Zhan, W. S. el-Deiry, F. Carrier, T. Jacks, W. V. Walsh, B. S. Plunkett, B. Vogelstein and A. J. Fornace, Jr., A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71, 587-597 (1992).
19. F. Xia, X. Wang, Y-H. Wang, N-M. Tsang, D. W. Yandell, K. T. Kelsey and H. L. Liber, Altered p53 status correlates with differences in sensitivity to radiation-induced mutation and apoptosis in two closely related human lymphoblast lines. Cancer Res. 55, 12-15 (1995).
20. M. Oren, W. Maltzman and A. J. Levine, Post-translational regulation of the 54K cellular tumor antigen in normal and transformed cells. Mol. Cell Biol. 1, 101-110 (1981).
21. C. G. Maki and P. M. Howley, Ubiquitination of p53 and p21 is differentially affected by ionizing and UV radiation. Mol. Cell. Biol. 17, 355-363 (1997).
22. J. Minowada, T. Ohnuma and G. E. Moore, Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes. J. Natl. Cancer Inst. 49, 891-895 (1972).
23. T. Han, J. L. Pauly and J. Minowada, In vitro preferential effect of irradiation on cultured T lymphoid cell line. Clin. Exp. Immunol. 17, 455-462 (1974).
24. +-dependent amino acid transport in human T (Molt-4) and human B (RPMI 1788) lymphoid cells. Radiat. Res. 80, 512-522 (1979).
25. H. Nakano, K. Kurihara, M. Okamoto, S. Toné and K. Shinohara, Heat-induced apoptosis and p53 in cultured mammalian cells. Int. J. Radiat. Biol. 71, 519-529 (1997).
26. K. Shinohara and H. Nakano, Interphase death and reproductive death in X-irradiated MOLT-4 cells. Radiat. Res. 135, 197-205 (1993).
27. U. K. Laemmli, Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685 (1970).
28. H. Towbin, T. Staehelin and J. Gordon, Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc. Natl. Acad. Sci. USA 76, 4350-4354 (1979).
29. P. Chomczynski and N. Sacchi, Single-step of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159 (1987).
30. C. A. Smith, G. T. Williams, R. Kingston, E. J. Jenkinson and J. J. T. Owen, Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature 337, 181-184 (1989).
31. J. M. Greenberg, R. Gonzalez-Sarmiento, D. C. Arthur, C. W. Wikowski, B. J. Streifel and H. Kersey, Immunophenotypic and cytogenetic analysis of Molt-3 and Molt-4: Human T-lymphoid cell lines with rearrangement of chromosome 7. Blood 72, 1755-1760 (1988).
32. 1 arrest in two closely related human lymphoblast cell lines that differ in p53 status. J. Biol. Chem. 270, 11033-11036 (1995).
33. W. Zhen, C. M. Denault, K. Loviscek, S. Walter, L. Geng and A. T. M. Vaughan, The relative radiosensitivity of TK6 and WI-L2-NS lymphoblastoid cells derived from a common source is primarily determined by their p53 mutational status. Mutat. Res. 346, 85-92 (1995).
34. M. Hollstein, D. Sidransky, B. Vogelstein and C. C. Harris, p53 mutations in human cancers. Science 253, 49-53 (1991).
35. M. S. Greenblatt, W. P. Bennett, M. Hollstein and C. C. Harris, Mutation in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis. Cancer Res. 54, 4855-4878 (1994).
36. J. Cheng and M. Haas, Frequent mutation in the p53 tumor suppressor gene in human leukemia T-cell lines. Mol. Cell. Biol. 10, 5502-5509 (1990).
37. V. T. K. Chow, H. H. Quek and E. P. C. Tock, Alternative splicing of the p53 tumor suppressor gene in the Molt-4 T-lymphoblastic leukemia cell line. Cancer Lett. 73, 141-148 (1993).
38. E. Yonish-Rouach, D. Resnitzky, J. Lotem, L. Sachs, A. Kimchi and M. Oren, Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 352, 345-347 (1991).
39. P. Shaw, R. Bovey, S. Tardy, R. Sahli, B. Sordat and J. Costa, Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc. Natl. Acad. Sci. USA 89, 4495-4499 (1992).
40. M. Scheffner, J. M. Huibregtse, R. D. Vierstra and P. M. Howly, The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75, 495-505 (1993).
41. C. G. Maki, J. M. Huibregtse and P. M. Howly, In vivo ubiquitination and proteasome-mediated degradation of p53. Cancer Res. 56, 2649-2654 (1996).
42. K. Shinohara, M. Tomioka, H. Nakano, S. Toné, H. Ito and S. Kawashima, Apoptosis induction resulting from proteasome inhibition. Biochem. J. 317, 385-388 (1996).
43. U. G. Lopes, P. Erhardt, R. Yao and G. M. Cooper, p53-dependent induction of apoptosis by proteasome inhibitors. J. Biol. Chem. 272, 12893-12896 (1997).
44. Y. Haupt, R. Maya, A. Kazaz and M. Oren, Mdm2 promotes the rapid degradation of p53. Nature 387, 296-299 (1997).
45. M. H. G. Kubbutat, S. N. Jones and K. H. Vousden, Regulation of p53 stability by Mdm2. Nature 387, 299-303 (1997).
46. R. Honda, H. Tanaka and H. Yasuda, Oncoprotein MDM2 is a ubiquitin ligase E3 for tumour suppressor p53. FEBS Lett. 420, 25-27 (1997).
47. Y. Break, T. Juven, R. Haffner and M. Oren, MDM2 expression is induced by wild type p53 activity. EMBO J. 12, 461-468 (1993).
48. J. Momand, G. P. Zambetti, D. C. Olson, D. George and A. J. Levine, The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69, 1237-1245 (1992).
49. S-Y. Shieh, M. Ikeda, Y. Taya and C. Prives, DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91, 325-334 (1997).
50. S. Banin, L. Moyal, S-Y. Shieh, Y. Taya, C. W. Anderson, L. Chessa, N. I. Smorodinsky, C. Prives, Y. Reiss, Y. Shiloh and Y. Ziv, Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281, 1674-1677 (1998).
51. C. E. Canman, D-S. Lim, K. A. Cimprich, Y. Taya, K. Tamai, K. Sakaguchi, E. Appella, M. B. Kastan and J. D. Siliciano, Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281, 1677-1679 (1998).
52. L. M. Grimm, A. L. Goldberg, G. G. Poirier, L. M. Schwartz and B. A. Osborn, Proteasomes play an essential role in thymocyte apoptosis. EMBO J. 15, 3835-3844 (1996).
53. C. L. Sentman, J. R. Shutter, D. Hockenbery, O. Kanagawa and S. J. Korsmeyer, bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67, 879-888 (1991).
54. Z. N. Oltvai, C. L. Milliman and S. J. Korsmeyer, Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74, 609-619 (1993).
55. T. Miyashita and J. C. Reed, Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80, 293-299 (1995).
56. C. M. Knudson, K. S. K. Tung, W. G. Tourtellotte, G. A. J. Brown and S. J. Korsmeyer, Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 270, 96-99 (1995).
57. Y. Xu and D. Baltimore, Dual roles of ATM in the cellular response to radiation and in cell growth control. Genes Dev. 10, 2401-2410 (1996).